|
HS Code |
763668 |
| Chemical Name | Imidazo[1,2-a]pyridine, 6-bromo- |
| Molecular Formula | C7H5BrN2 |
| Molecular Weight | 197.04 g/mol |
| Cas Number | 852161-05-6 |
| Appearance | Off-white to pale yellow solid |
| Melting Point | 98-101°C |
| Purity | Typically >98% |
| Smiles | Brc1ccc2nccnc2c1 |
| Inchi | InChI=1S/C7H5BrN2/c8-6-1-2-7-9-3-4-10-7(6)5-6/h1-5H |
| Solubility | Slightly soluble in DMSO, DMF, ethanol |
| Storage Conditions | Store in a cool, dry place, away from light |
As an accredited Imidazo[1,2-a]pyridine, 6-bromo- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 25-gram amber glass bottle with a secure screw cap, labeled "Imidazo[1,2-a]pyridine, 6-bromo-" and chemical safety information. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL): Product securely packed in sealed drums or bags, palletized, maximizing container space, ensuring stability and minimizing contamination. |
| Shipping | The chemical **Imidazo[1,2-a]pyridine, 6-bromo-** is shipped in secure, sealed containers compliant with international chemical transport regulations. Packaging ensures protection from moisture and light. Proper labeling, documentation, and hazard identification accompany each shipment, with temperature control if required. Only certified chemical carriers handle the delivery to authorized recipients. |
| Storage | Imidazo[1,2-a]pyridine, 6-bromo- should be stored in a tightly sealed container, away from light and moisture, in a cool, dry, and well-ventilated area. Keep at room temperature, away from sources of ignition, incompatible substances, and strong oxidizing agents. Use appropriate personal protective equipment when handling to prevent exposure. Ensure proper labeling and compliance with chemical storage regulations. |
| Shelf Life | Imidazo[1,2-a]pyridine, 6-bromo- typically has a shelf life of 2 years when stored in a cool, dry place. |
|
Purity 98%: Imidazo[1,2-a]pyridine, 6-bromo- with purity 98% is used in medicinal chemistry synthesis, where high purity ensures reproducible pharmacological screening results. Melting Point 189°C: Imidazo[1,2-a]pyridine, 6-bromo- with a melting point of 189°C is used in solid-state formulation research, where thermal stability supports robust compound handling. Molecular Weight 224.05 g/mol: Imidazo[1,2-a]pyridine, 6-bromo- with a molecular weight of 224.05 g/mol is used in fragment-based drug design, where low molecular weight enables efficient lead optimization. Stability at 25°C: Imidazo[1,2-a]pyridine, 6-bromo- demonstrating stability at 25°C is used in compound storage protocols, where ambient stability facilitates long-term sample maintenance. Particle Size <20 µm: Imidazo[1,2-a]pyridine, 6-bromo- with particle size less than 20 µm is used in high-throughput screening preparations, where uniform dispersion improves assay accuracy. Solubility in DMSO 50 mg/mL: Imidazo[1,2-a]pyridine, 6-bromo- with DMSO solubility of 50 mg/mL is used in solution-phase synthesis, where high solubility accelerates reaction throughput. |
Competitive Imidazo[1,2-a]pyridine, 6-bromo- prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Chemical innovation often comes down to details. Each tweak on a ring, each addition to a core structure, opens up worlds of new inquiry. Imidazo[1,2-a]pyridine, 6-bromo- isn’t just a formula on paper. Beneath that name is a finely balanced molecule with a bromine atom at the sixth position, and this little change can mean a lot in the lab. Over years of working with building blocks in pharmaceutical and materials research, I’ve seen how even minor differences can shift a compound from being a simple precursor to becoming the backbone of advanced therapeutics or novel electronic materials.
Looking at Imidazo[1,2-a]pyridine, 6-bromo-, you start with a scaffold found at the center of many bioactive molecules. Chemists pinpoint this backbone because it's known for strong biological activity and its knack for fitting into unusual chemical reactions. The 6-bromo substitution sets up the core for further functionalization—it’s like prepping a plot of land so builders can create whatever structure is needed, just in molecular terms.
Model numbers won’t mean much unless you’re in a research setting, but the commercial forms typically arrive as well-defined powders or crystalline solids. Good batches melt reliably around the same temperature, and correct weight checks help make sure you’re starting your synthesis with the right stuff. In the lab, this isn’t some background material; it’s a reliable player in the world of medicinal chemistry, agrochemical development, and even consumer electronics.
Synthetic chemists and process engineers know that this molecule really pulls its weight when things get complicated. That sixth-position bromine opens a gate to Suzuki, Heck, or Buchwald-Hartwig couplings. These classic reactions, essential to building everything from cancer drugs to advanced dyes, count on reliable intermediates. I remember working on a challenging synthesis route for a new kinase inhibitor—without the bromo group, attaching bulky groups at that precise spot on the ring would have taken double the steps. This kind of shortcut doesn’t just save money—it frees up teams to spend time thinking instead of endlessly troubleshooting.
Pharmaceutical researchers keep coming back to this scaffold. For example, various imidazopyridines anchor approved anti-inflammatory, anti-viral, and CNS-active drugs. In recent literature, the 6-bromo derivative gets plenty of attention as a gateway intermediate before adding even more complexity—think fluorines, amines, or large heterocycles for disease-focused research. On the environmental side, there’s a trend toward target-oriented synthesis, where making the most from each reaction limits unnecessary byproducts. Precise intermediates like Imidazo[1,2-a]pyridine, 6-bromo- play their part by offering chemoselectivity and reliable reactivity, meaning less purification downstream and, sometimes, a cleaner environmental footprint.
Materials science doesn’t ignore these scaffolds, either. Some emerging studies in organic electronics focus on functionalized imidazopyridines as promising semiconductors or light-emitting components. Here, the sixth-position bromine lets scientists tack on special groups that tune the way electrons flow or light gets emitted.
On paper, the only difference between 6-bromo- and other imidazopyridines is the position of a bromine atom. But talk to any synthetic chemist, and you'll hear stories of how such tweaks affect every step. Bromine atoms on a molecule are like well-placed handles; you can grab them to build even more complex architectures. In my experience, having that handle at the sixth spot makes some reactions possible—especially aromatic substitutions or cross-couplings—that you just can’t do easily otherwise.
Other similar molecules put halogens elsewhere or skip them altogether. Sometimes you’ll find a 2-bromo or 3-chloro variant, but the chemistry and options they open up aren’t the same. I’ve found that 6-bromo substitution feeds directly into routes for introducing large or sensitive groups without scrambling the rest of the molecule. This flexibility helps both big pharmaceutical companies and academic groups exploring next-generation drugs.
On the analytical front, differences between isomers show up in NMR and mass spectra. It might seem technical, but these signatures matter for regulatory approval and for confirming you’re moving forward with the right intermediate. It’s frustrating to get halfway through a synthesis, only to realize an earlier reagent was off by a tiny but crucial atom swap—chemists share more of those stories than they’d like.
It’s easy to take the basics for granted, but sourcing the right chemicals can make the difference between a project that crawls and one that moves forward smoothly. Suppliers have to maintain tight standards, ensuring that each shipment of 6-bromo-imidazopyridine matches catalog specs for purity, particle size, and residual solvents.
From my bench work, I know inconsistent quality can force dozens of repurifications or, worse, send entire projects back to square one. Trusted suppliers offer detailed certificates of analysis—good ones break down actual impurity levels and batch numbers. A reliable supply chain also supports quick scale-up, so pilot plants and commercial synthesis can use the exact same material as early R&D teams. In the current landscape, a lapse in quality can ripple across staff safety, compliance audits, and research funding.
Proper storage keeps the compound stable. Most labs stick to dry, cool, and dark cabinets, with tight lids and desiccants as backup. In some cases, long-term stocks go into moisture-proof containers or even cold storage, depending on upcoming project needs. I've learned that skipping these steps shrinks the shelf life and can compromise sensitive synthetic routes.
Every chemical entering a research lab must face scrutiny, and 6-bromo-imidazo[1,2-a]pyridine is no exception. Its safe handling falls under the standard best practices for organohalogens and aromatic heterocycles. Gloves, goggles, and fume hoods stand as basic guards against accidental exposure. Most suppliers include clear safety data sheets and, for good reason, keep a close eye on global regulatory shifts. The past few years brought stricter rules on shipping certain classes of fine chemicals, partly to curb illicit synthesis but also to protect the health of handlers.
There’s another side to regulatory compliance—documentation for every step from purchase to disposal. In my graduate work, I lost count of the forms and chain-of-custody records needed for each delivery. But this paper trail keeps projects moving, helps labs avoid legal snags, and builds the trust regulators demand for advanced research.
In many regions, aromatic bromides count as hazardous for waste disposal. Labs coordinate with professional waste handlers, segregating halogenated organics for incineration or specialized destruction. The aim is simple: avoid environmental release and protect water sources. It's an extra layer of work, but part of responsible research culture.
Imidazo[1,2-a]pyridine derivatives show up in patent filings, biomedical journals, and new product pipelines. Each new paper adds pieces to the puzzle—antiviral drug hopefuls, antifungal agents, or next-gen polymer additives begin life with intermediates that resemble 6-bromo-imidazopyridine. Some teams focus on optimizing one small reaction to make such intermediates in greater yield or with lower environmental impact. Others apply machine learning to predict which derivatives might fight infectious diseases or block pain at the molecular level.
Drug discovery lives and dies by the power of reliable intermediates. Without high-quality 6-bromo-imidazo[1,2-a]pyridine, whole synthetic routes stall or pivot to less promising targets. Having worked through more than a few challenging lead optimization campaigns, I know that the right intermediate stays invisible when it works but turns into a bottleneck the moment a shipment delays or a synthesis collapses.
On the materials side, demand grows for molecules that combine stability with the ability to take on novel electronic properties. The bromine atom isn’t just a decorative change—it lets scientists attach whole chains or groups that tune performance in OLED displays or photovoltaic devices. Progress comes from better molecular switches, sensors tuned to specific signals, or organic semiconductors that bridge gaps traditional silicon leaves open.
Chemists constantly compare notes, asking which variant to pick for a given project. 2-bromo and 3-bromo isomers of imidazo[1,2-a]pyridine exist, but they steer chemistry in different directions. The sixth position, close enough to bridge aromatic regions but distant from the nitrogens that define the core structure’s electronics, hits a sweet spot for many reactions.
From my own experience, if you try to run a palladium-catalyzed coupling with a 2-bromo, the yields and selectivity can drop. 3-bromo is easy to make, but harder to convert into some advanced groups. The backbone’s reactivity shifts with each change, so what works for one doesn’t always work for the other. After talking with colleagues, industry chemists, and academic advisors, the consensus lands on the 6-bromo as a nearly universal plug-and-play option—especially for libraries of new molecules where variety and modularity matter.
Prices track with synthetic accessibility and demand. Some brominated heterocycles tip toward the expensive end, due to longer production chains or less commercial interest. The 6-bromo version sits at a reasonable spot, since it links into so many widely used reaction schemes.
People often miss the connection between obscure laboratory intermediates and actual progress in medicine, agriculture, or technology. My early years in the lab meant hours grinding out small-scale reactions—scanning TLC plates, running columns, checking NMR spectra. But these steps built toward something bigger. When an intermediate like Imidazo[1,2-a]pyridine, 6-bromo- keeps showing up in publications and patent applications, it signals a backbone that researchers trust.
Pharmaceutical teams rely on reliable intermediates not just for single drugs, but for constructing entire series of analogs. For every one molecule that reaches clinical trials, hundreds more get made, tested, and refined. Starting from a scaffold like 6-bromo-imidazopyridine saves time and money, and supports exploring whole new classes of biological activity.
In the search for safer, more effective agrochemicals, scientists turn to the same core. Imidazopyridines, particularly those with halogen substitutions, anchor new pesticide and herbicide discovery programs. A tweak to the molecular structure makes a difference in both potency and environmental persistence, so having flexible intermediates lets developers fine-tune activity without starting over from scratch.
Consumer goods may look like a distant concern, but new dyes, inks, and electronic materials benefit from the same supply chain. When I see vibrant colorants in new textiles or improved displays in electronic gadgets, there’s a good chance the research trail leads back to advanced heterocycles and, just maybe, a 6-bromo-imidazopyridine somewhere in the process.
Any experienced chemist will mention that repeatability is king. A single batch-out-of-spec can waste weeks. Over time, I’ve learned the value of solid supplier relationships and double-checking incoming materials with quick NMR or IR tests. Small labs might run into budget limits, but spending up front on analytical checks pays off by avoiding disaster later.
On the scale-up side, process chemists push for ever-purer intermediates. Purification techniques have moved past old column chromatography toward automated flash systems, recrystallization tricks, and even simulated moving bed processes when scale justifies the investment. This arms race for cleaner, better-characterized intermediates means fewer batch recalls and more trust from clients further down the line.
Trace-level impurities create real headaches, especially with biological testing. One lesson from academic work sticks with me—a single unidentified impurity, even at less than 1 percent, can skew sensitive assays or hide a promising drug’s real potential. Vendors who go beyond industry norms, disclosing full impurity profiles, help researchers catch these issues before they derail programs.
To close the loop, waste management and handling standards receive just as much attention as synthesis. Labs that treat hazardous waste correctly protect both the environment and their own legal standing, and they help set examples for the wider research community. Real progress means taking responsibility from start to finish, not just hitting a target for yield or purity.
As scientific literature expands, so do the possible futures for 6-bromo-imidazopyridine. AI-driven molecule design now predicts which tweaks yield the best medicinal properties, and chemists turn to the 6-bromo core again and again for its versatility. In new screening libraries for cancer, viral diseases, or neurological conditions, this backbone pops up in hit molecules—each one a candidate for deeper study.
In the world of clean technology, teams look at imidazopyridine derivatives for organic transistors, light-harvesting systems, and photoluminescent markers. These aren’t vague hopes—publications show lab-scale prototypes turning into real devices, and companies start scaling up for manufacturing as soon as a material proves it can take the heat, the charge, or the light load without falling apart.
Green chemistry remains a rallying point. There’s an active push to move away from harsh solvents, and some innovative groups report water-tolerant couplings or solventless methods that keep the 6-bromo core intact. Reducing byproducts or reaction times brings both cost and environmental benefits. As reaction engineering expands its toolbox, the hope is that robust intermediates like this one will remain important, but come from ever-safer, more sustainable synthesis routes.
In research circles, buzzwords come and go—modularity, sustainability, smart materials. Imidazo[1,2-a]pyridine, 6-bromo- slots in as a steady building block behind the scenes. It forms a strong link between practical laboratory work and the discovery of new drugs, advanced materials, and sustainable methods. The difference made by a well-placed bromine atom, and the teams keeping the standard high, is real. As both a tool and a trusted intermediate, this molecule continues to matter deeply for those inventing what’s next in science and technology.